<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Improving ethnic and racial diversity in biomarker-driven clinical trials: A proof of concept with the BASECAMP-1 master prescreening study of patients with high-risk solid tumors with human leukocyte antigen-A*02 (HLA-A*02) loss of heterozygosity (LOH)	</title>
	<atom:link href="https://www.tempus.com/publications/improving-ethnic-and-racial-diversity-in-biomarker-driven-clinical-trials-a-proof-of-concept-with-the-basecamp-1-master-prescreening-study-of-patients-with-high-risk-solid-tumors-with-human-leukocyte/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.tempus.com/publications/improving-ethnic-and-racial-diversity-in-biomarker-driven-clinical-trials-a-proof-of-concept-with-the-basecamp-1-master-prescreening-study-of-patients-with-high-risk-solid-tumors-with-human-leukocyte/</link>
	<description>AI-enabled precision medicine</description>
	<lastBuildDate>Thu, 13 Jun 2024 16:30:32 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
</channel>
</rss>

<!--
Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/

Page Caching using Disk: Enhanced (Page is feed) 

Served from: www.tempus.com @ 2025-03-24 21:04:19 by W3 Total Cache
-->